<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Oral Cancer News &#187; HPV16</title>
	<atom:link href="http://oralcancernews.org/wp/tag/hpv16/feed/" rel="self" type="application/rss+xml" />
	<link>http://oralcancernews.org/wp</link>
	<description>The Oral Cancer Foundation News Archive</description>
	<lastBuildDate>Tue, 27 Jul 2010 19:28:38 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>HPV is changing the face of head and neck cancers</title>
		<link>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/</link>
		<comments>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/#comments</comments>
		<pubDate>Sun, 27 Jun 2010 12:26:29 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[brush sampling]]></category>
		<category><![CDATA[Cervarix]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV positive]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[immunotherapy]]></category>
		<category><![CDATA[lymphocytes]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[radiation]]></category>
		<category><![CDATA[risk factor]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[smoking]]></category>
		<category><![CDATA[tobacco]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8940</guid>
		<description><![CDATA[
			
				
			
		
Source: www.hemonctoday.com
Author:  Christen Cona
In February, at the Multidisciplinary Head and Neck Cancer Symposium in Chandler, Ariz., Maura Gillison, MD, PhD, professor and Jeg Coughlin Chair of Cancer Research at The Ohio State University in Columbus, presented data that showed that the proportion of all head and neck squamous cell cancers that were of the oropharynx [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-is-changing-the-face-of-head-and-neck-cancers/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>BT Pharma secures EUR 13.1million (USD 17.7 million) in capital funding and changes its name to Genticel</title>
		<link>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/</link>
		<comments>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 04:40:51 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[HPV18]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[immunotherapies]]></category>
		<category><![CDATA[ProCervix]]></category>
		<category><![CDATA[vaccine]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=8085</guid>
		<description><![CDATA[
			
				
			
		
Source: pharmalive.com/News
Author: press release
BT Pharma, a biopharmaceutical company developing innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today that it has raised EUR 13.1 million in additional funding and changed its name to Genticel. AGF Private Equity led the round, which brought in three new investors, IRDI (Institut Régional de Développement [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/bt-pharma-secures-eur-13-1million-usd-17-7-million-in-capital-funding-and-changes-its-name-to-genticel/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma</title>
		<link>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/</link>
		<comments>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/#comments</comments>
		<pubDate>Sun, 20 Dec 2009 06:04:23 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cohort]]></category>
		<category><![CDATA[disease-free survival]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7618</guid>
		<description><![CDATA[
			
				
			
		
Source: Journal of Clinical Oncology, Vol 27, No 36 (December 20), 2009: pp. 6213-6221
Authors: Wei Shi et al.
Purpose:
A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative real-time polymerase chain [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma</title>
		<link>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma/</link>
		<comments>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma/#comments</comments>
		<pubDate>Thu, 05 Nov 2009 14:30:00 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[epidermal growth factor]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[immunohistochemistry]]></category>
		<category><![CDATA[p53]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7201</guid>
		<description><![CDATA[
			
				
			
		
Source: Journal of Clinical Oncology, 10.1200/JCO.2009.23.1670
Author: Wei Shi et al.
Purpose:
A significant proportion of oropharyngeal squamous cell carcinomas (OSCC) are associated with the human papilloma virus (HPV), particularly HPV16. The optimal method for HPV determination on archival materials however, remains unclear. We compared a quantitative real-time polymerase chain reaction (qRT-PCR) assay for HPV16 mRNA to a [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/comparative-prognostic-value-of-hpv16-e6-mrna-compared-with-in-situ-hybridization-for-human-oropharyngeal-squamous-carcinoma/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PMH finding may help some tonsil cancer patients avoid chemotherapy</title>
		<link>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/</link>
		<comments>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/#comments</comments>
		<pubDate>Wed, 04 Nov 2009 19:27:48 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[chemotherapy]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=7178</guid>
		<description><![CDATA[
			
				
			
		
Source: www.sciencecodex.com
Author: staff
Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer (&#8220;tonsil cancer&#8221;) harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. For some patients, this may mean successful treatment with radiation alone and avoiding the side effects [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/pmh-finding-may-help-some-tonsil-cancer-patients-avoid-chemotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV data may aid vaccine&#8217;s effectiveness</title>
		<link>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness-2/</link>
		<comments>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness-2/#comments</comments>
		<pubDate>Mon, 13 Apr 2009 16:08:21 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[DNA]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[HPV18]]></category>
		<category><![CDATA[HPV31]]></category>
		<category><![CDATA[HPV33]]></category>
		<category><![CDATA[HPV45]]></category>
		<category><![CDATA[human papillomavirus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=4366</guid>
		<description><![CDATA[
			
				
			
		
Source: health.usnews.com
Author: staff
The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study. It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those diagnosed with [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HPV data may aid vaccine&#8217;s effectiveness</title>
		<link>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness/</link>
		<comments>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness/#comments</comments>
		<pubDate>Fri, 27 Mar 2009 16:09:38 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[HPV18]]></category>
		<category><![CDATA[human papillomavirus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=2617</guid>
		<description><![CDATA[
			
				
			
		
Source: health.usnews.com
Author: staff
The majority of invasive cervical cancers in New Mexico in the 1980s and 1990s contained DNA from human papillomavirus type 16 (HPV16) and HPV type 18 (HPV18), says a new study.
It also found that women diagnosed with HPV16- or HPV18-positive cancers were an average of five years younger than those diagnosed with cancers [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/hpv-data-may-aid-vaccines-effectiveness/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral rinses used for tracking HPV-positive head and neck cancers hold promise for screening</title>
		<link>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-hold-promise-for-screening/</link>
		<comments>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-hold-promise-for-screening/#comments</comments>
		<pubDate>Sun, 28 Dec 2008 14:55:56 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papillomavirus]]></category>
		<category><![CDATA[oral rinse]]></category>
		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=909</guid>
		<description><![CDATA[
			
				
			
		
Source: American Association for Cancer Research
Author: staff
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.
In the study, researchers at Johns Hopkins University used oral rinses and targeted DNA [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-hold-promise-for-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Oral rinses used for tracking HPV-positive head and neck cancers holds promise for cancer screening</title>
		<link>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-holds-promise-for-cancer-screening/</link>
		<comments>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-holds-promise-for-cancer-screening/#comments</comments>
		<pubDate>Fri, 31 Oct 2008 14:32:31 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[HPV]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[oral rinse]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=611</guid>
		<description><![CDATA[
			
				
			
		
Source: www.eurekalert.com
Author: staff
A study published in the journal Clinical Cancer Research, a journal of the American Association for Cancer Research, validates a non-invasive screening method with future potential for detection of human papillomavirus (HPV)-positive head and neck cancers.
In the study, researchers at Johns Hopkins University used oral rinses and targeted DNA amplification to track and [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/oral-rinses-used-for-tracking-hpv-positive-head-and-neck-cancers-holds-promise-for-cancer-screening/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gardasil vaccine eradicating human papillomavirus infections</title>
		<link>http://oralcancernews.org/wp/gardasil-vaccine-eradicating-human-papillomavirus-infections/</link>
		<comments>http://oralcancernews.org/wp/gardasil-vaccine-eradicating-human-papillomavirus-infections/#comments</comments>
		<pubDate>Thu, 24 Jul 2008 17:56:12 +0000</pubDate>
		<dc:creator>Oral Cancer Foundation News Team</dc:creator>
				<category><![CDATA[Oral Cancer News]]></category>
		<category><![CDATA[cervical cancer]]></category>
		<category><![CDATA[Gardasil]]></category>
		<category><![CDATA[HPV16]]></category>
		<category><![CDATA[human papilloma virus]]></category>

		<guid isPermaLink="false">http://oralcancernews.org/wp/?p=78</guid>
		<description><![CDATA[
			
				
			
		
Source: news.com.au
Author: Kate Sikora
The new cervical cancer vaccine is expected to almost eradicate human papillomavirus (HPV) infections in Australian women by 2050 if the high rate of immunization amongst girls continues.

Research to be released today by the Cancer Council NSW reveals the number of new HPV cases in women will fall by more than 50 [...]]]></description>
		<wfw:commentRss>http://oralcancernews.org/wp/gardasil-vaccine-eradicating-human-papillomavirus-infections/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
